The production of recombinant pharmaceutical proteins in plants
JKC Ma, PMW Drake, P Christou - Nature reviews genetics, 2003 - nature.com
Imagine a world in which any protein, either naturally occurring or designed by man, could
be produced safely, inexpensively and in almost unlimited quantities using only simple …
be produced safely, inexpensively and in almost unlimited quantities using only simple …
Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants
The use of plants for medicinal purposes dates back thousands of years but genetic
engineering of plants to produce desired biopharmaceuticals is much more recent. As the …
engineering of plants to produce desired biopharmaceuticals is much more recent. As the …
[BOOK][B] Introduction to plant biotechnology (3/e)
HS Chawla - 2011 - taylorfrancis.com
This book has been written to meet the needs of students for biotechnology courses at
various levels of undergraduate and graduate studies. This book covers all the important …
various levels of undergraduate and graduate studies. This book covers all the important …
Vaccination against coronaviruses in domestic animals
IR Tizard - Vaccine, 2020 - Elsevier
The current pandemic of COVID-19 has set off an urgent search for an effective vaccine. This
search may well benefit from the experiences of the animal health profession in the …
search may well benefit from the experiences of the animal health profession in the …
Edible vaccines: Promises and challenges
VM Kurup, J Thomas - Molecular biotechnology, 2020 - Springer
Vaccines are biological preparations that improve immunity to particular diseases and form
an important innovation of 19th century research. It contains a protein that resembles a …
an important innovation of 19th century research. It contains a protein that resembles a …
Approaches to achieve high‐level heterologous protein production in plants
SJ Streatfield - Plant biotechnology journal, 2007 - Wiley Online Library
Plants offer an alternative to microbial fermentation and animal cell cultures for the
production of recombinant proteins. For protein pharmaceuticals, plant systems are …
production of recombinant proteins. For protein pharmaceuticals, plant systems are …
Rice-based mucosal vaccine as a global strategy for cold-chain-and needle-free vaccination
T Nochi, H Takagi, Y Yuki, L Yang… - Proceedings of the …, 2007 - National Acad Sciences
Capable of inducing antigen-specific immune responses in both systemic and mucosal
compartments without the use of syringe and needle, mucosal vaccination is considered …
compartments without the use of syringe and needle, mucosal vaccination is considered …
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
K Dhama, S Natesan, M Iqbal Yatoo… - Human Vaccines & …, 2020 - Taylor & Francis
Globally, researchers are undertaking significant efforts to design and develop effective
vaccines, therapeutics, and antiviral drugs to curb the spread of coronavirus disease 2019 …
vaccines, therapeutics, and antiviral drugs to curb the spread of coronavirus disease 2019 …
Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond
V Yusibov, SJ Streatfield, N Kushnir - Human vaccines, 2011 - Taylor & Francis
In the last few years, plants have become an increasingly attractive platform for recombinant
protein production. This builds on two decades of research, starting with transgenic …
protein production. This builds on two decades of research, starting with transgenic …
Plants as bioreactors: recent developments and emerging opportunities
In recent years, the use of plants as bioreactors has emerged as an exciting area of research
and significant advances have created new opportunities. The driving forces behind the …
and significant advances have created new opportunities. The driving forces behind the …